Brainstorm cell therapeutics announces full year 2024 financial results and provides corporate update

Conference call and webcast at 8:30 a.m. eastern time today new york , march 31, 2025 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the fiscal year ended december 31, 2024, and provided a corporate update.
BCLI Ratings Summary
BCLI Quant Ranking